Cargando…

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial

BACKGROUND: Meta-analyses suggest that reboxetine may be less effective than other antidepressants. Such comparisons may be biased by lower adherence to reboxetine and subsequent handling of missing outcome data. This study illustrates how to adjust for differential non-adherence and hence derive an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiles, N. J., Fischer, K., Cowen, P., Nutt, D., Peters, T. J., Lewis, G., White, I. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131263/ https://www.ncbi.nlm.nih.gov/pubmed/25065692 http://dx.doi.org/10.1017/S0033291714000221

Ejemplares similares

Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial
por: Gougoulaki, Marilia, et al.
Publicado: (2021)

GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
por: Thomas, Laura, et al.
Publicado: (2008)

Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial
por: Green, Amy, et al.
Publicado: (2014)

Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases
por: Stein, Alan, et al.
Publicado: (2012)

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals
por: Crawford, Andrew A., et al.
Publicado: (2014)

Anti-Candidal Activity of Reboxetine and Sertraline Antidepressants: Effects on Pre-Formed Biofilms
por: Ahmed, Eman Ibrahim, et al.
Publicado: (2023)

Reboxetine-induced urinary hesitancy
por: Borade, Suresh, et al.
Publicado: (2005)

Effect of single doses of citalopram and reboxetine on urethral pressure: A randomized, double‐blind, placebo‐ and active‐controlled three‐period crossover study in healthy women
por: Christoffersen, Thea, et al.
Publicado: (2022)

O001 Reboxetine reduces obstructive sleep apnea severity: a randomized trial
por: Altree, T, et al.
Publicado: (2021)

A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
por: Duffy, Larisa, et al.
Publicado: (2019)

Computational Study of Photodegradation Process and Conversion Products of the Antidepressant Citalopram in Water
por: Shen, Yifan, et al.
Publicado: (2023)

Impact of the antidepressant citalopram on the behaviour of two different life stages of brown trout
por: Ziegler, Michael, et al.
Publicado: (2020)

DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests
por: Szopa, Aleksandra, et al.
Publicado: (2018)

Enhanced Antidepressant-Like Effects of Electroacupuncture Combined with Citalopram in a Rat Model of Depression
por: Yang, Jian, et al.
Publicado: (2013)

Effect of a single dose of citalopram on amygdala response to emotional faces
por: Murphy, Susannah E., et al.
Publicado: (2009)

Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism
por: Kreiner, Grzegorz, et al.
Publicado: (2019)

Gut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats
por: Aydin, Sinem, et al.
Publicado: (2021)

Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
por: Rodriguez-Sanchez, Julia, et al.
Publicado: (2023)

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
por: Perger, Elisa, et al.
Publicado: (2023)

The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice
por: Donat, Antonia, et al.
Publicado: (2023)

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
por: Eyding, Dirk, et al.
Publicado: (2010)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Citalopram and group psychotherapy in breast cancer patients: A randomized clinical trial
por: Nikbakhsh, Novin, et al.
Publicado: (2018)

Reboxetine Improves Auditory Attention and Increases Norepinephrine Levels in the Auditory Cortex of Chronically Stressed Rats
por: Pérez-Valenzuela, Catherine, et al.
Publicado: (2016)

Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants
por: Alkhafaji, Ali A, et al.
Publicado: (2012)

Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge
por: Klöbl, Manfred, et al.
Publicado: (2020)

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial
por: Drye, Lea T., et al.
Publicado: (2014)

A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD)
por: Hashemian, F, et al.
Publicado: (2011)

Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects
por: Metzger, Coraline D, et al.
Publicado: (2015)

Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study
por: Zheng, Guoxun, et al.
Publicado: (2016)

Effectiveness of Reboxetine in Treatment of Outpatient Children and Adolescents with Attention Deficit-Hyperactivity Disorder with Comorbid Anxiety Disorders
por: Riahi, Forough, et al.
Publicado: (2013)

The use of citalopram for the treatment of cataplexy()
por: Fonseca, Hassana de Almeida, et al.
Publicado: (2014)

Zebrafish (Danio rerio) embryo-larvae locomotor activity data analysis: Evaluating anxiolytic effects of the antidepressant compound citalopram
por: Pohl, Johannes
Publicado: (2019)

Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers
por: Taylor, MJ, et al.
Publicado: (2010)

Citalopram-induced ventricular tachycardia under general anesthesia
por: Roche-Kelly, Emma, et al.
Publicado: (2018)

Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task
por: Liu, Yia-Ping, et al.
Publicado: (2009)

Erotic Stimulus Processing under Amisulpride and Reboxetine: A Placebo-Controlled fMRI Study in Healthy Subjects
por: Graf, Heiko, et al.
Publicado: (2015)

Double-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder
por: Hosseini, Fatemeh, et al.
Publicado: (2015)

Double blind, randomised trial to compare efficacy of escitalopram versus citalopram for interferon induced depression in hepatitis C patients
por: Shakeel, Uzma, et al.
Publicado: (2020)

Aqueous Extract of Pomegranate Alone or in Combination with Citalopram Produces Antidepressant-Like Effects in an Animal Model of Menopause: Participation of Estrogen Receptors
por: Valdés-Sustaita, Brenda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_566fr51b7ucjcm8stmqrbskat6